ALLIVE, ALLogeneic Iron inVEstigators trial; eLPI, enhanced labile plasma iron; IOL, iron overload; MVA, multivariate analysis; NRM, non-relapse mortality; OS, overall survival; SCT, (hematopoietic) stem cell transplant.
Wermke M, et al. Lancet Haematol 2018;5:e201–e210.